The role of catecholamines in seizure susceptibility: New results using genetically engineered mice

Pharmacology and Therapeutics

Volumn 94, Issue 3, 2002, Pages 213-233

  Weinshenker, David ^a   Szot, Patricia ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c GRECC   (United States)

Author keywords

Catecholamine; Dopamine; Epilepsy; Knockout; Norepinephrine; Seizure

Indexed keywords

2 (2 CHLORO 5 TRIFLUOROMETHYLPHENYLIMINO)IMIDAZOLIDINE; ADENOSINE TRIPHOSPHATE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; BRIMONIDINE; CATECHOLAMINE; CIRAZOLINE; CLONIDINE; CORYNANTHINE; DOPAMINE; GALANIN; GUANFACINE; IDAZOXAN; LOFEXIDINE; METHOXAMINE; NEUROPEPTIDE Y; NORADRENALIN; OXIDOPAMINE; OXYMETAZOLINE; PHENTOLAMINE; PHENYLEPHRINE; PRAZOSIN; RESERPINE; SEROTONIN; UNINDEXED DRUG; YOHIMBINE;

ANTICONVULSANT ACTIVITY; CELL ACTIVATION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG POTENCY; DRUG RECEPTOR BINDING; EPILEPSY; HUMAN; KNOCKOUT MOUSE; LOCUS CERULEUS; NERVE CELL EXCITABILITY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RECEPTOR DENSITY; REVIEW; SEIZURE SUSCEPTIBILITY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ANIMAL; DISEASE PREDISPOSITION; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; SEIZURE;

ANIMAL; CATECHOLAMINES; DISEASE SUSCEPTIBILITY; MICE; MICE, KNOCKOUT; SEIZURES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; ANIMALS;

EID: 0036019857     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(02)00218-8     Document Type: Review

References (250)

1. 3 dopamine receptor gene is associated with hyperactivity in mice
2. Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: The role of hippocampal dopamine D1 receptors
3. Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: The role of hippocampal D2 receptors
4. Effects of dopamine D3 receptor agonists on pilocarpine-induced limbic seizures in the rat
5. Anticonvulsant action of SCH 23390 in the straitum of the rat
6. D-2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D-2 receptors in the striatum, but not in the substantia nigra
7. Anticonvulsant effect of striatal dopamine D2 receptor stimulation: Dependence on cortical circuits?
8. Opposite effects of stimulation of D1 and D2 dopamine receptors in the expression of motor seizures in mouse and rat
9. Proconvulsant effect of SKF 38393 mediated by nigral D1 receptors
10. 2A-adrenergic receptor knockout mice
11. Strychnine-induced seizures in mice: The role of noradrenaline
12. Gamma Aminobutyric acid mediation of the anticonvulsant effect of clonidine on pentylenetetrazol-induced seizures in mice
13. The effects of chronic desmethylimipramine on entorhinal cortical kindling in rats
14. The substantia nigra pars reticulata, seizures and Fos expression
15. 4 dopamine receptor protein in the CNS using anti-receptor antisera
16. Effects of atropine, reserpine, 6-hydroxydopamine, and handling on seizure development in the rat
17. Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine
18. Sodium valproate induced alterations in monoamine levels in different regions of the rat brain
19. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y
20. Alpha 2-adrenoceptors modulate kainic acid-induced limbic seizures
21. Psychobiology of novelty seeking and drug seeking behavior
22. Dopamine D1 receptor modulation of pilocarpine-induced convulsions
23. Dopaminergic regulation of epileptic activity
24. Grafts of fetal locus coeruleus neurons in rat amygdala-piriform cortex suppress seizure development in hippocampal kindling
25. Convergent thalamic and mesencephalic projections to the anterior medial cortex in the rat
26. Convergent prefrontal and nigral projections to the striatum of the rat
27. Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazol: Metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy
28. Seizure suppression in kindling epilepsy by intrahippocampal locus coeruleus grafts: Evidence for an alpha-2-adrenoreceptor mediated mechanism
29. Host regulation of noradrenaline release from grafts of seizure-suppressant locus coeruleus neurons
30. Regulation of norepinephrine transporter and tyrosine hydroxylase mRNAs after kainic acid-induced seizures
31. Effect of combined reserpine and ECS on electroshock seizure thresholds in mice
32. Activation of substantia nigra neurons: Role in the propagation of seizures in kindled rats
33. +
34. Motor expression of kainic acid seizures is attenuated by dopamine depletion in mice
35. Effect of DSP4 on hippocampal kindling in rats
36. Neuroprotective role of dopamine against hippocampal cell death
37. Alpha-1 adrenoceptors are decreased in human epileptic foci
38. Regional brain abnormalities in norepinephrine uptake and dopamine beta-hydroxylase activity in the genetically epilepsy-prone rat
39. Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse
40. DSP-4 treatment accelerates kindling
41. 1b-adrenergic receptor
42. 2-adrenergic receptor-G-protein interactions
43. A facilitation of reserpine on the central nervous system
44. Biochemical and radiohistochemical analyses of alpha-2 adrenergic receptors in the kindling model of epilepsy
45. Effects of drugs affecting the noradrenergic system on convulsions in the quaking mouse
46. 2 adrenergic receptor gene
47. Acute effects of antidepressants on hippocampal seizures
48. Intracerebral grafting of fetal dorsal pons in genetically epilepsy-prone rats: Effects on audiogenic-induced seizures
49. Effects of intraventricular locus coeruleus transplants on seizure severity in genetically epilepsy-prone rats following depletion of brain norepinephrine
50. Neurite extension of developing noradrenergic neurons is impaired in genetically epilepsy-prone rats (GEPR-3s): An in vitro study on the locus coeruleus
51. Audiogenic seizure susceptible rats
52. Norepinephrine and epinephrine
53. Characteristics of accelerated kindling after depletion of noradrenaline in adult rats
54. Role of forebrain catecholamines in amygdaloid kindling
55. Potentiation of amygdaloid kindling and metrazol-induced seizures by 6-hydroxydopamine in rats
56. Evidence for a preferential role of central noradrenergic neurons in electrically induced convulsions and activity of various anticonvulsants in the rat
57. Mesolimbic dopamine receptor increases two weeks following hippocampal kindling
58. Mesolimbic dopaminergic supersensitivity following electrical kindling of the amygdala
59. Effect of neurotoxin DSP4 on EEG power spectra in the rat acute model of epilepsy
60. Antagonism of N-methyl-D,L-aspartic acid-induced convulsions by antiepileptic drugs and other agents
61. Anticonvulsant drugs and the genetically epilepsy-prone rat
62. Indices of noradrenergic function in the central nervous system of seizure-naive genetically epilepsy-prone rats
63. Antidepressants and seizures: Clinical anecdotes overshadow neuroscience
64. Noradrenergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats
65. Supersensitivity to the anticonvulsant and proconvulsant activity of clonidine following noradrenaline depletion induced by 6-hydroxydopamine
66. Serotonin and dopamine afferents to the locus coeruleus: A biochemical study after lesioning of the ventral mesencephalic tegmental-A10 region and the raphe dorsalis
67. Monoaminergic denervation of the rat hippocampus: Microiontophoretic studies on pre- and postsynaptic supersensitivity to norepinephrine and serotonin
68. Acute cocaine toxicity: Antagonism by agents interacting with adrenoceptors
69. Emerging insights into mechanisms of epilepsy: Implications for new antiepileptic drug development
70. 1A dopamine receptors
71. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli
72. Seizures
73. Fos in locus coeruleus neurons following audiogenic seizure in the genetically epilepsy-prone rat: Comparison to electroshock and pentylenetetrazol seizure models
74. Effects of pentylenetetrazol-induced seizures on dopamine and norepinephrine levels and on glucose utilization in various brain regions of the developing rat
75. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
76. The genetically epilepsy-prone rat
77. Modulation of the audiogenic seizure network by noradrenergic and glutamatergic receptors of the deep layers of superior colliculus
78. Catecholamine innervation of the basal forebrain. III. Olfactory bulb anterior olfactory nuclei, olfactory tubercle and piriform cortex
79. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum
80. Catecholamine innervation of the basal forbrain. II. Amygdala, suprahinal cortex and entorhinal cortex
81. MPTP and convulsive response in rodents
82. Dopamine agonists and cobalt-induced epilepsy in the rat
83. Stimulation of locus coeruleus in man. Preliminary trials for spasticity and epilepsy
84. Locus coeruleus noradrenaline system and focal penicillin hippocampal epilepsy: Neurophysiological study
85. A proconvulsant action of selective alpha 2-adrenoceptor antagonists
86. Nucleus locus ceruleus: New evidence of anatomical and physiological specificity
87. The origin of the dopamine nerve terminal in limbic and frontal cortex. Evidence for meso-cortico dopamine neurons
88. Proconvulsant action of α2-adrenoceptor antagonists in mice: Possible involvement of α1-adrenoceptors
89. Progression and generalization of seizure discharge: Anatomical and neurochemical substrates
90. Persistent increases in dopamine D2 receptor mRNA expression in the basal ganglia following kindling
91. Alpha-2 receptors mediate an endogenous noradrenergic suppression of kindling development
92. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
93. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto-and heteroreceptor-mediated control of release
94. Levels of catechols in epileptogenic and nonepileptogenic regions of the human brain
95. Paradoxical effects of d-amphetamine upon seizure susceptibility in 2 selectively bred lines of mice
96. Relationships between norepinephrine and cyclic nucleotides in brain and seizure activity
97. 3H]prazosin
98. Role of dopaminergic and GABA-ergic interactions in seizure susceptibility
99. 14C-2-deoxyglucose method
100. Distinct features of seizures induced by cocaine and amphetamine analogs
101. A burst-dependent hippocampal excitability defect elicited by potassium at the developmental onset of spike-wave seizures in the Tottering mutant
102. Pharmaco-histochemical evidence of the existence of dopamine nerve terminals in the limbic cortex
103. Anti-convulsant activity of diazepam and clonidine on metaldehyde-induced seizures in mice: Effects on brain gamma-amino butyric acid concentrations and monoamine oxidase activity
104. Dopamine (3-hydroxytyramine) and brain function
105. Noradrenergic influences on sound-induced seizures
106. The time course of noradrenergic pre- and postsynaptic activity during chronic desipramine treatment
107. Exploring the pharmacology of the pro-convulsant effects of alpha 2-adrenoceptor antagonists in mice
108. 2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine
109. Brain adrenoceptor binding sites in mice susceptible (DBA/2J) and resistant (C57 Bl/6) to audiogenic seizures
110. Audiogenic seizures in rats: Relation to noradrenergic neurons of the locus coeruleus
111. Abnormalities in norepinephrine turnover rate in the central nervous system of the genetically epilepsy-prone rat
112. Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study
113. 2-chloroethyl)-N-ethyl-2-bromobenzylamine) - A useful denervation tool for central and peripheral noradrenaline neurons
114. Actions of the hypnotic anaesthetic, dexmedetomidine, on noradrenaline release and cell firing in rat locus coeruleus slices
115. Central monoamines and convulsive thresholds in mice and rats
116. Dopamine-deficient mice are hypersensitive to dopamine receptor agonists
117. Clonidine and methohexital-induced epileptic magnetoencephalographic discharges in patients with focal epilepsies
118. The projections of A8, A9 and A10 dopaminergic cell bodies: Evidence for a nigral-hypothalamic-median eminence dopaminergic pathway
119. Brain dopamine and seizure susceptibility in mice
120. Influence of antidepressant drugs on seizure susceptibility and the anticonvulsant activity of valproate in mice
121. Evaluation of monoaminergic receptors in the genetically epilepsy prone rat
122. Noradrenaline and 5-hydroxytryptamine release in the hippocampus during seizures induced by hippocampal kindling stimulation: An in vivo microdialysis study
123. Seizure suppression in kindling epilepsy by intracerebral implants of GABA-but not by noradrenaline-releasing polymer matrices
124. Semiquantitative analysis of immunoreactivities of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the locus coeruleus of desipramine-treated mice
125. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation
126. Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model
127. Actions of clonidine on convulsions and behaviour
128. Catecholamines and the adrenal medulla
129. Differences in dopamine beta-hydroxylase immunoreactivity between the brains of genetically epilepsy-prone and Sprague-Dawley rats
130. Potentiation by yohimbine of pentylenetetrazol-induced seizures in rats: Role of alpha 2 adrenergic receptors
131. Evidence that the dorsal raphe area is involved in the effect of clonidine against pentylenetetrazole-induced seizures in rats
132. Influence of catecholaminergic agents on the convulsant effect of corasol in rats
133. 1A-deficient mutant mice
134. Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: Effects of drugs affecting noradrenergic transmission
135. Suppression of an eplieptiform type of electrocortical activity in the rat by stimulation in the vicinity of locus coeruleus
136. Anatomy of the dopaminergic neuron systems in the rat brain
137. Mesencephalic dopamine neurons projecting to neocortex
138. Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog
139. 2-adrenergic receptor subtypes b and c
140. A possible role for beta-adrenergic receptors in the expression of audiogenic seizures
141. Differential effect of yohimbine in several chemical models of convulsions in mice
142. Differential effects of DSP-4 administration on regional brain norepinephrine turnover in rats
143. Influence of pharmacological manipulation of inhibitory and excitatory neurotransmitter systems on seizure behavior in the Mongolian gerbil
144. Studies on the involvement of dopamine D-1 and D-2 receptors in the anticonvulsant effect of dopamine agonists in various rodent models of epilepsy
145. Comparison of drugs with different selectivity for central alpha 1- and alpha 2-adrenoceptors in animal models of epilepsy
146. Role of central beta-adrenoceptors in the control of pentylenetetrazol-induced convulsions in rats
147. 2a-adrenergic receptor subtype
148. Anticonvulsant activity of some beta-adrenoceptor blocking agents in mice
149. Catecholamines and convulsions
150. The role of the neurotransmitters in the epilepsies
151. Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus
152. Modulation of hippocampal excitability and seizures by galanin
153. Amygdala kindling in rats: Facilitation after local amygdala norepinephrine depletion with 6-hydroxydopamine
154. Effect of norepinephrine depletion on dorsal hippocampus kindling in rats
155. Effect of clonidine on amygdala kindling in normal and 6-hydroxydopamine-pretreated rats
156. The effects of apomorphine, amphetamine and L-DOPA on maximal electroshock convulsions: A comparative study in the rat and mouse
157. Dopamine receptor mRNA expression in human striatum and neocortex
158. Chronic imipramine treatment normalizes levels of tyrosine hydroxylase in the locus coeruleus of chronically stressed rats
159. Effect of chronic administration of phenytoin on regional monoamine levels in rat brain
160. Effects of drugs affecting noradrenergic neurotransmission in rats with spontaneous petit mal-like seizures
161. Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s)
162. Role of norepinephrine in forebrain and brainstem seizures: Chemical lesioning of locus ceruleus with DSP4
163. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain
164. Central nervous system effects of four beta-adrenergic receptor blocking agents
165. Purinergic modulation of the seizure threshold for pentylenetetrazol in the rat
166. Suppression of penicillin-induced focal epileptiform activity by locus ceruleus stimulation: Mediation by an alpha 1-adrenoceptor
167. Abnormality of alpha 1-adrenergic receptors in the frontal cortex of epileptic rats
168. A single gene error of noradrenergic axon growth synchronizes central neurones
169. Altered hippocampal network excitability in the hypernoradrenergic mutant mouse tottering
170. 2 receptors in mediating cocaine-induced convulsions
171. Effects of dopamine D1 and D2 receptor agonists and antagonists on seizures induced by chemoconvulsants in mice
172. The role of alpha-adrenoceptors in the regulation of pentylenetetrazol convulsions in mice
173. Anticonvulsant effects of clonidine mediated through central alpha2-adrenoceptors
174. The relationship between alpha 2-adrenoceptor selectivity and anticonvulsant effect in a series of clonidine-like drugs
175. Role of beta-adrenoceptors in the anticonvulsant effect of propranolol on leptazol-induced convulsions in rats
176. Infusions of alpha-2 noradrenergic agonists and antagonists into the amygdala: Effects on kindling
177. Chronic but not acute treatment with antidepressants enhances the electroconvulsive seizure response in rats
178. Modification of seizure activity by electrical stimulation. II. Motor seizure
179. Cocaine-induced convulsions: Pharmacological antagonism at serotonergic, muscarinic and sigma receptors
180. Targeted disruption of the mouse β1-adrenergic receptor gene: Developmental and cardiovascular effects
181. Seizures associated with antidepressants: A review
182. D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs
183. Stress and the mesocorticolimbic dopamine system
184. 4 receptor-deficient mice display cortical hyperexcitability
185. Alpha-and beta-adrenoceptors: From the gene to the clinic. 2. Structure-activity relationships and therapeutic applications
186. Catecholamine regulation of neocortical spindling in DBA/2 mice
187. Reduction of seizure frequency with clomipramine in patients with complex partial seizures
188. Changes in tyrosine hydroxylase mRNA expression in the rat locus coeruleus following acute or chronic treatment with valproic acid
189. Inhibition of amygdaloid kindling by chronic pretreatment with cocaine or methamphetamine
190. Comparative study of tiapride and neuroleptics with anti-dopamine activity on convulsive seizures in mice
191. Origin of dopaminergic innervation of the rat hippocampal formation
192. Detection of an epileptic mirror focus after oral application of clonidine
193. Repeated administration of desmethylimipramine blocks the reserpine-induced increase in tyrosine hydroxylase mRNA in locus coeruleus neurons of the rat
194. Mechanisms underlying the anti-epileptic efficacy of the ketogenic diet
195. Study on the anticonvulsant activity of clonidine against pentylenetetrazol-induced seizures in rats: Pharmacological evidence of alpha 2-adrenoceptors mediation
196. Topiramate: Preclinical evaluation of structurally novel anticonvulsant
197. Enzyme changes in actively spiking areas of human epileptic cerebral cortex
198. Transient changes in cortical alpha 1 adrenoceptors and seizure threshold following electroconvulsive seizures in rats
199. The alpha 2-adrenoreceptor agonist clonidine suppresses seizures, whereas the alpha 2-adrenoreceptor antagonist idazoxan promotes seizures in amygdala-kindled kittens: A comparison of amygdala and pontine microinfusion effects
200. Activation of the locus coeruleus after amygdaloid kindling
201. Seizures in rats treated with kainic acid induce Fos-like immunoreactivity in locus coeruleus
202. Flurothyl-induced seizures in rats activate Fos in brainstem catecholaminergic neurons
203. Mesencephalic dopaminergic neurons: Functional role
204. Efferents and afferents of the ventral tegmental-A10 region studied after local injection of 3H-leucine and horseradish peroxidase
205. Anatomical relationships between the ventral mesencephalic tegmentum-A10 region and the locus coeruleus as demonstrated by anterograde and retrograde tracing techniques
206. The role of dopamine in epilepsy
207. Seizure promotion by D1 agonists does not correlate with other dopaminergic properties
208. Effects of dopamine receptor stimulation and blockade on Ro 4-1284-induced enhancement of electroshock seizures
209. Aggravation of penicillin-induced epilepsy in rats with locus ceruleus lesions
210. 2-adrenoceptor that blocks coupling to potassium but not calcium currents
211. 3-adrenergic receptor gene
212. The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat
213. Viral gene delivery selectively restores feeding and prevents lethality of dopamine-deficient mice
214. Feeding behavior in dopamine-deficient mice
215. Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice
216. Alterations in mRNA expression of systems that regulate neurotransmitter synaptic content in seizure-naive genetically epilepsy-prone rat (GEPR): Transporter proteins and rate-limiting synthesizing enzymes for norepinephrine, dopamine and serotonin
217. Effect of pentylenetetrazol on the expression of tyrosine hydroxylase mRNA and norepinephrine and dopamine transporter mRNA
218. Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli
219. Norepinephrine is required for the anticonvulsant effect of the ketogenic diet
220. Differential effects of a two-minute open-field session on dopamine utilization in the frontal corticies of BALB/C and C57BL/6 mice
221. Dopaminergic terminals in the rat cortex
222. Noradrenaline is essential for mouse fetal development
223. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase
224. Facilitation of focal cobalt-induced epilepsy after lesions of the noradrenergic locus coeruleus system
225. Altered patterns of catecholaminergic fibers in focal cortical dysplasia in two patients with partial seizures
226. Involvement of the noradrenergic system in the seizures of epileptic El mice
227. Age- and seizure-related changes in noradrenaline and dopamine in several brain regions of epileptic El mice
228. Dopamine-sensitive anticonvulsant site in the rat striatum
229. Dopamine control of seizure propagation: Intranigral dopamine D1 agonist SKF 38393 enhances susceptibility to seizures
230. Stereotaxic mapping of the monoamine pathways in the rat brain
231. Antidepressant interactions with corticotropin-releasing factor in the noradrenergic nucleus locus coeruleus
232. MPTP is proconvulsant acutely but has no long-term effects in rodent models of seizure and epilepsy
233. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
234. Convulsive thresholds and severity and the anticonvulsant effect of phenobarbital and phenytoin in adult rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine during postnatal development
235. Genetic approaches to studying norepinephrine function: Knockout of the mouse norepinephrine transporter gene
236. 2 adrenoreceptor agonists inhibit pentylenetetrazole-induced seizures in mice lacking norepinephrine
237. Antikindling effect of LC stimulation: Mediation by ascending noradrenergic projections
238. Parallel upregulation of catecholamine-synthesizing enzymes in rat brain and adrenal gland: Effects of reserpine and correlation with immediate early gene expression
239. 14C-2-deoxyglucose uptake and Fos immunocytochemistry
240. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex
241. Picrotoxin-, kainic acid- and seizure-induced Fos in brainstem, with special reference to catecholamine cell groups
242. 2A messenger RNA expression
243. Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog
244. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors
245. Norepinephrine modulates seizures induced by quinolinic acid in rats: Selective and distinct roles of alpha-adrenoceptor subtypes
246. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses
247. Thalamic deficiency in norepinephrine release detected via intracerebral microdialysis: A synaptic determinant of seizure predisposition in the genetically epilepsy-prone rat
248. Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): A microinjection study
249. Age-specific effects of noradrenergic alpha-2 agonist clonidine on the development of amygdaloid kindling in developing rats
250. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic